Making it in NYC: a Little Luck & a lot of Grit
3:30 PM — 6:00 PM
The road to success in the concrete jungle is a long one...
The road to success in the concrete jungle is a long one with no guarantees, especially when it comes to the start-up space. There are many factors to success, skill, determination, money, the right team…some may even say the biggest factor is luck. Join us as we examine just how much luck is involved in turning one idea into a tangible innovative product, solution or business.
At JLABS @ NYC, we invite you to a fireside chat with founders who have been there before and can shine a light on what it really takes to build a company from the ground up. Spoiler alert: it takes a little more hustle and determination than “luck of the draw”!
03:30 PM | Registration Opens and Networking
04:00 PM | Fireside Chat and Q&A
05:00 PM | Networking Session
06:00 PM | Program Close
Presentation & Lunch
$25 | General Public
$35 | At the door
Includes presentation, Q&A and refreshments.
New York Genome Center
101 6th Avenue
New York, NY 10013
Jeremy A. Abbate | VP & Publisher, Scientific American MIND and SA Worldview
Mr. Jeremy Abbate is responsible for developing and executing new media programs, brand extensions and collaborative ventures serving the international opinion leadership that turns to Scientific American and its related titles for the best views of the future. As the founder of Scientific American’s Worldview enterprise, a global exploration of health and life science innovation produced in collaboration with the Biotechnology Innovation Organization, he leads the teams that create its content, distribution network and visibility platforms for its sponsors.
To learn more about Mr. Jeremy Abbate, click this link.
Cristina Dolan | Co-Founder & COO, IxLedger
Ms. Cristina Dolan is Co-Founder and COO of iXledger an alternative marketplace for insurance based on blockchain. As a former executive at a software company that offers award winning global multi-asset institutional trading solutions in the cloud, she is applying her knowledge of traditional marketplaces to the creation of next generation blockchain enabled marketplaces in combination with advanced technologies through digital transformation to create efficiencies and opportunities.
To learn more about Ms. Cristina Dolan, click this link.
Maria Luisa Pineda PhD | Co-Founder and CEO, Envisagenics, Inc
Dr. Maria Luisa Pineda is the co-founder and CEO of Envisagenics, Inc. a biotech spinout of Cold Spring Harbor Laboratory that has developed a machine learning platform to predict disease-causing aberrant splicing through the analysis of massive amounts of RNA-seq data. With this platform, Envisagenics will identify biologically relevant and druggable targets and design RNA-therapeutics that will be validated in preclinical and clinical studies.
To learn more about Dr. Maria Luisa Pineda, click this link.
+FIVE POINTSFive Points lecture series bring leading scientists from around the world for an in-depth discussion of their work with students, researchers and clinicians from the New York Genome Center, its member institutions, and others in the medical/scientific community. While Five Points lectures are free and open to the general public, these lectures are most beneficial to scientists, clinicians and researchers who wish to accelerate their research through the use of DNA sequencing technology and bioinformatics. Five Points lectures often frame five or so key points, in a nod to the series’ name — followed by 15 minutes of Q&A, and 30 minutes of networking over hors d’oeuvres and cocktails. These afternoon events are held in the Center’s state-of-the-art ground-floor auditorium starting at 4 pm.
+EVENING TALKSThe New York Genome Center’s Evening Talks events feature distinguished experts from around the world sharing genomic insights and research. They are intended to showcase and explain high science to the non-scientific community. Speakers present the latest research findings and explain its implication for helping improve clinical care for a wide array of serious diseases. The lecture is followed by a lively question-and-answer session and a post-event reception of hors d’oeuvres and cocktails. These popular free public events are held in the Center’s state-of-the-art ground-floor auditorium starting at 6:30 pm. The Evening Talks Series is sponsored by The New York Community Trust – Pyewacket Fund.
+New York Cancer Genomics Research NetworkTo advance collaborative efforts on cancer genomics, the New York Genome Center (NYGC) hosts meetings on the first Tuesday of every month to bring together leading cancer researchers, clinicians and postdocs from the NYGC’s Institutional Founding Members and other key academic institutions. The organizers include Drs. Harold Varmus (Weill Cornell Medicine & NYGC), Marcin Imielinski (Weill Cornell Medicine & NYGC), Ross Levine (Memorial Sloan Kettering Cancer Center) and Sohail Tavazoie (The Rockefeller University).